Tag Archives: Featured

Digital Health: An Imperative Tool for Pharma The role of digital tools, such as mobile devices/apps, wearables, virtual assistants, and artificial intelligence (AI), in healthcare is quickly expanding. Pharmaceutical companies are increasingly integrating digital health into all services offered, including for treatment, follow-up, and prevention purposes. Additionally, they are shifting their focus from only providing […]

Source: https://www.linkedin.com/pulse/evaluation-clinical-trial-costs-barriers-drug-luca-dezzani-md/ The complete analysis of the costs and barriers to drug development in 2018. All the expenses to conduct clinical trials and the split by disease areas Clinical trials are a crucial part of the drug development process. Pharmaceutical companies conduct clinical trials to demonstrate safety and efficacy in order to gain approval from regulatory […]

By Karin Bauer, VP Client Services, SGK Health Healthcare is an empathy-driven industry. But as healthcare consumers seek to become more empowered, changes in healthcare information gathering and sharing across systems have created a disconnect between the quantity of information available to empower care choices and the quality of care that patients receive. To win consumer confidence […]

Besides the introduction we did, there was no unifying framework, so far we had seeing different models in an isolated way. Putting every framework in context is the purpose of this article. We believe that the best way to present this is by graphically depicting how the different models stack together in the following diagram: […]

Tactical war games are generally used for strengthening detailing in product launches and to develop successful counter-messages to competitors that are gaining share. Definitions and main hypothesis: A tactical war game is a simulation of a typical sales visit to get a thorough knowledge and understanding of the competition’s sales approach to develop own alternatives […]

LIFE SCIENCES FORCES OF CHANGE New and often asymmetrical competition is reshaping the market. Disruption is the new normal, the pace of innovation is accelerating, and data more important than ever. Furthermore, we have entered the era of the Millennial healthcare providers (HCPs) & patients with technology-dependent expectations and empowerment regarding care treatment, research and […]

By Neil Grubert, market access specialist, analyst and author. EU Study on Off-Label Prescribing In recent years, the pharmaceutical industry has been concerned by the precedent set by the off-label use on purely economic grounds of Roche/Genentech/Chugai’s Avastin (bevacizumab) as a replacement for Roche/Novartis’s Lucentis (ranibizumab) in the management of wet age-related macular degeneration (AMD). The […]

By Steve Figman The pace, scope, and variety of challenges we face as executives in Pharma are both invigorating and overwhelming. They span macro trends such as personalized medicine, real-world-evidence (RWE), onerous regulatory pressures, collaborative R&D and Digital health, as well as those specific to our businesses including post-merger integration, loss of exclusivity, market access […]

The Complete List and Analysis of the Best Selling Oncology Drugs in 2017. All the Top Oncology Products in the Pharmaceutical and Biotechnology Industry with detailed performance and future trends Oncology remains the largest disease area in the pharmaceutical business followed by diabetology, rheumatology, anti-virals, and others. Total revenues for the 10 best selling oncology […]

Pharmaceutical companies live and die by their pipelines. Then, product launch excellence is key in the pharmaceutical business, as most of a new molecule’s success depends on the product launch. The current pharmaceutical market is tough and there are not many new products that can claim to be first-in-class or best-in-class. Additionally, many companies are […]